The Unlikely Union of Bard and Bainbridge
Executive Summary
CR Bard bought Bainbridge Sciences three years ago as part of an effort to expand the portfolio of its highly regarded urology franchise into high tech, high margin areas. Proponents saw it as an opportunity to get Bard Urological division moving again. Opponents wondered what the device company wanted in a complex business it didn't know anything about.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.